ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1812

Inflammasome and UPR activation in monocytes of HLA B27 positive children with Enthesitis related arthritis category of JIA

Shivika Guleria1 and Amita Aggarwal2, 1SGPGIMS, Lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

Meeting: ACR Convergence 2025

Keywords: cytokines, Gene Expression, Inflammasome, Juvenile idiopathic arthritis, Monocytes/macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Enthesitis related arthritis (ERA) is a chronic immune-inflammatory disease with unknown etiology. HLA-B27 is the strongest risk factor predisposing to ERA like Spondyloarthritis (SpA). In adult SpA, HLA-B27 has been associated with unfolded protein response (UPR) and inflammasome activation in monocytes. However, no data is available in ERA.

Methods: Patients with ERA and healthy controls (HC) were enrolled after informed consent. Monocytes from ERA patients and HC were separated from PBMCs/SFMCs using MACS columns. Purity and viability were checked by flow cytometry. Monocytes were stimulated with LPS (100ng/ml) and mRNA levels of TLR4, NLRP3, IL-1β, IL-18, BiP, sXBP1, CHOP, IRE1α and IL-23R were measured by qPCR. Protein levels of IL-1β and IL-18 in the culture supernatant were measured by ELISA. The caspase-1 activity was measured by flow cytometry using the Caspase 1 Kit.

Results: 12 HLA B27 positive, 6 HLA B27 negative ERA patients and 6 HLA B27 negative HC were included. Clinical features such as arthritis, enthesitis and sacroiliitis were more common in HLA-B27 positive ERA patients than in B27 negative patients (Table1). HLA B27 positive patients had higher disease activity compared with HLA B27 negative patients. Monocytes of HLA-B27 positive ERA patients had more than 1.5-fold increase in mRNA expression of IL-1β, NLRP3, and TLR4 than HC. On the other hand, monocytes from HLA-B27 positive ERA patients also had more than 1.5-fold increase in mRNA expression of IL-18, NLRP3, and TLR4 as compared to monocytes from HLA-B27 negative patients. Monocytes from HLA B27 positive ERA patients produce more IL-1β than HLA B27 negative HC (p< 0.01). After LPS stimulation, there was further increase in mRNA expression of all the 4 genes and IL-1β production (p< 0.001). In comparison to HLA-B27 negative HC (p< 0.05) and HLA -B27 negative ERA patients (p< 0.05), the caspase expression was greater in HLA B27 positive ERA patients (Figure1). Expression of mRNA related to UPR activation (BiP and sXBP1, IRE1α) were similar in all 3 groups. Paired analysis of monocytes from SFMCs of HLA B27 positive patients revealed 1.5-fold higher expression of IL-18, NLRP3, TLR4, BiP, sXBP 1, and IRE1α as compared to PBMCs. IL23R mRNA expression was only present in the monocytes isolated from SFMCs.

Conclusion: Activation of inflammasome pathway in the circulating monocytes and activation of both ER stress and inflammasome pathway at local site may contribute to higher inflammation burden and more severe disease in HLA-B27 positive ERA patients.

Supporting image 1Table1. Clinical Characteristics and demographic details of the JIA-ERA patients

Supporting image 2Figure1. Workflow of experiments

Supporting image 3Figure2. a) Relative mRNA expression of inflammasome markers in the monocytes isolated from HLA B27 positive ERA patients compared to HLA B27 negative patients at baseline b) IL-1β levels in the culture supernatant of unstimulated monocytes of HLA B27 negative HC, HLA B27 negative patients, and HLA B27 positive ERA patients c) Mean Fluorescence Intensity (MFI) of FLICA FITC in HLA B27 negative HC, HLA B27 negative patients, and HLA B27 positive ERA patients d) Relative mRNA expression of inflammasome markers in the monocytes isolated from HLA B27 positive ERA patients after LPS stimulation e) IL-1β levels in the culture supernatant of LPS stimulated monocytes of HLA B27 positive ERA patients f) Relative mRNA expression of UPR activation markers in the monocytes isolated from HLA B27 positive ERA patients compared to HLA B27 negative patients g) Relative mRNA expression of inflammasome markers in monocytes from SFMCs compared to monocytes from PBMCs of HLA B27 positive ERA patients h) Relative mRNA expression of UPR activation markers in monocytes from SFMCs compared to monocytes from PBMCs of HLA B27 positive ERA patients


Disclosures: S. Guleria: None; A. Aggarwal: None.

To cite this abstract in AMA style:

Guleria S, Aggarwal A. Inflammasome and UPR activation in monocytes of HLA B27 positive children with Enthesitis related arthritis category of JIA [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/inflammasome-and-upr-activation-in-monocytes-of-hla-b27-positive-children-with-enthesitis-related-arthritis-category-of-jia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammasome-and-upr-activation-in-monocytes-of-hla-b27-positive-children-with-enthesitis-related-arthritis-category-of-jia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology